Overview

Safety Study to Evaluate the Contact Sensitizing Potential of Topically Applied ZuraPrep™ and ZuraPrep™ Without IPA

Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
This is a safety study to determine the skin sensitization potential of ZuraPrep™ and ZuraPrep™ without isopropyl alcohol (IPA) after repetitive patch applications to skin of human subjects. Indications of both sensitization and skin irritation will be evaluated.
Phase:
Phase 1
Details
Lead Sponsor:
Zurex Pharma, Inc.
Treatments:
Chlorhexidine
Chlorhexidine gluconate